Espin R, Medina-Jover F, Siguenza-Andrade J, Farran-Matas S, Mateo F, Figueras A
NAR Cancer. 2025; 7(1):zcaf007.
PMID: 40061566
PMC: 11886861.
DOI: 10.1093/narcan/zcaf007.
Chia M, Bulat F, Gaunt A, Ros S, Wright A, Sawle A
Oncogene. 2024; 44(9):563-574.
PMID: 39639170
PMC: 11850285.
DOI: 10.1038/s41388-024-03231-w.
Hu Y, Liu W, Fang W, Dong Y, Zhang H, Luo Q
Mol Biomed. 2024; 5(1):63.
PMID: 39609317
PMC: 11604893.
DOI: 10.1186/s43556-024-00229-4.
Jing T, Tang D
Clin Transl Oncol. 2024; .
PMID: 39455494
DOI: 10.1007/s12094-024-03757-1.
Ubanako P, Mirza S, Ruff P, Penny C
Front Mol Biosci. 2024; 11:1447953.
PMID: 39355533
PMC: 11442288.
DOI: 10.3389/fmolb.2024.1447953.
Reciprocal interactions between lncRNAs and MYC in colorectal cancer: partners in crime.
Lei Z, Zhu Z, Yao Z, Dai X, Dong Y, Chen B
Cell Death Dis. 2024; 15(7):539.
PMID: 39075086
PMC: 11286766.
DOI: 10.1038/s41419-024-06918-w.
Function of Steroid Receptor Coactivators in T Cells and Cancers: Implications for Cancer Immunotherapy.
Zhang W, Cao X, Wu H, Zhong X, Shi Y, Sun Z
Crit Rev Immunol. 2024; 44(6):111-126.
PMID: 38848298
PMC: 11902286.
DOI: 10.1615/CritRevImmunol.2024051613.
Acetate reprogrammes tumour metabolism and promotes PD-L1 expression and immune evasion by upregulating c-Myc.
Wang J, Yang Y, Shao F, Meng Y, Guo D, He J
Nat Metab. 2024; 6(5):914-932.
PMID: 38702440
DOI: 10.1038/s42255-024-01037-4.
Transcriptional regulation and post-translational modifications in the glycolytic pathway for targeted cancer therapy.
Ni X, Lu C, Xu G, Ma J
Acta Pharmacol Sin. 2024; 45(8):1533-1555.
PMID: 38622288
PMC: 11272797.
DOI: 10.1038/s41401-024-01264-1.
The m6A modification-mediated positive feedback between glycolytic lncRNA SLC2A1-DT and c-Myc promotes tumorigenesis of hepatocellular carcinoma.
Zeng Z, Wang J, Xu F, Hu P, Hu Y, Zhuo W
Int J Biol Sci. 2024; 20(5):1744-1762.
PMID: 38481809
PMC: 10929188.
DOI: 10.7150/ijbs.86658.
Metabolic reprogramming directed by super-enhancers in tumors: An emerging landscape.
Zhou Z, Li J, Ousmane D, Peng L, Yuan X, Wang J
Mol Ther. 2024; 32(3):572-579.
PMID: 38327048
PMC: 10928301.
DOI: 10.1016/j.ymthe.2024.02.003.
Mechanosensitive channel of large conductance enhances the mechanical stretching-induced upregulation of glycolysis and oxidative metabolism in Schwann cells.
Shan F, Zhang N, Yao X, Li Y, Wang Z, Zhang C
Cell Commun Signal. 2024; 22(1):93.
PMID: 38302971
PMC: 10835878.
DOI: 10.1186/s12964-024-01497-x.
Proteomic analysis of holocarboxylase synthetase deficient-MDA-MB-231 breast cancer cells revealed the biochemical changes associated with cell death, impaired growth signaling, and metabolism.
Sukjoi W, Young C, Acland M, Siritutsoontorn S, Roytrakul S, Klingler-Hoffmann M
Front Mol Biosci. 2024; 10:1250423.
PMID: 38283944
PMC: 10812114.
DOI: 10.3389/fmolb.2023.1250423.
The radiation- and chemo-sensitizing capacity of diclofenac can be predicted by a decreased lactate metabolism and stress response.
Schwab M, Bashiri Dezfouli A, Khosravi M, Alkotub B, Bauer L, Birgani M
Radiat Oncol. 2024; 19(1):7.
PMID: 38229111
PMC: 10790495.
DOI: 10.1186/s13014-024-02399-5.
The Aurora kinase inhibitor AT9283 inhibits Burkitt lymphoma growth by regulating Warburg effect.
Jiang K, Bai L, Wang C, Xiao X, Cheng Z, Peng H
PeerJ. 2023; 11:e16581.
PMID: 38099309
PMC: 10720464.
DOI: 10.7717/peerj.16581.
ATM inhibition blocks glucose metabolism and amplifies the sensitivity of resistant lung cancer cell lines to oncogene driver inhibitors.
Terlizzi C, De Rosa V, Iommelli F, Pezone A, Altobelli G, Maddalena M
Cancer Metab. 2023; 11(1):20.
PMID: 37932830
PMC: 10629204.
DOI: 10.1186/s40170-023-00320-4.
Formyl-peptide receptor 2 signalling triggers aerobic metabolism of glucose through Nox2-dependent modulation of pyruvate dehydrogenase activity.
Cimmino T, Pagano E, Stornaiuolo M, Esposito G, Ammendola R, Cattaneo F
Open Biol. 2023; 13(10):230336.
PMID: 37875162
PMC: 10597678.
DOI: 10.1098/rsob.230336.
Natural compounds: Wnt pathway inhibitors with therapeutic potential in lung cancer.
Shen X, Gao C, Li H, Liu C, Wang L, Li Y
Front Pharmacol. 2023; 14:1250893.
PMID: 37841927
PMC: 10568034.
DOI: 10.3389/fphar.2023.1250893.
Multifaceted roles of mitochondrial dysfunction in diseases: from powerhouses to saboteurs.
Prabhu S, Sujathan Nair A, Nirmala S
Arch Pharm Res. 2023; 46(9-10):723-743.
PMID: 37751031
DOI: 10.1007/s12272-023-01465-y.
E-box binding transcription factors in cancer.
Pan Y, van der Watt P, Kay S
Front Oncol. 2023; 13:1223208.
PMID: 37601651
PMC: 10437117.
DOI: 10.3389/fonc.2023.1223208.